Seroprevalence and durability of antibody responses to AstraZeneca vaccination in Ugandans with prior mild or asymptomatic COVID-19: implications for vaccine policy

por Serwanga, Jennifer, Baine, Claire, Mugaba, Susan, Ankunda, Violet, Auma, Betty Oliver, Oluka, Gerald Kevin, Kato, Laban, Kitabye, Isaac, Sembera, Jackson, Odoch, Geoffrey, Ejou, Peter, Nalumansi, Amina, Gombe, Ben, Musenero, Monica, Kaleebu, Pontiano
Publicado 2023

Rapid, early, and potent Spike-directed IgG, IgM, and IgA distinguish asymptomatic from mildly symptomatic COVID-19 in Uganda, with IgG persisting for 28 months

por Serwanga, Jennifer, Ankunda, Violet, Sembera, Jackson, Kato, Laban, Oluka, Gerald Kevin, Baine, Claire, Odoch, Geoffrey, Kayiwa, John, Auma, Betty Oliver, Jjuuko, Mark, Nsereko, Christopher, Cotten, Matthew, Onyachi, Nathan, Muwanga, Moses, Lutalo, Tom, Fox, Julie, Musenero, Monica, Kaleebu, Pontiano
Publicado 2023

Pre-pandemic SARS-CoV-2-specific IFN-γ and antibody responses were low in Ugandan samples and significantly reduced in HIV-positive specimens

por Nantambi, Hellen, Sembera, Jackson, Ankunda, Violet, Ssali, Ivan, Kalyebi, Arthur Watelo, Oluka, Gerald Kevin, Kato, Laban, Ubaldo, Bahemuka, Kibengo, Freddie, Katende, Joseph Ssebwana, Gombe, Ben, Baine, Claire, Odoch, Geoffrey, Mugaba, Susan, Sande, Obondo James, Kaleebu, Pontiano, Serwanga, Jennifer
Publicado 2023